MAGEN MULLANEY: Open Payments
NPI 1063759629 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 41 payments from 11 companies in 2025. Trend: 2023 $1,537 · 2024 $1,246 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $430 |
| GlaxoSmithKline, LLC. | 6 | $127 |
| Lilly USA, LLC | 5 | $119 |
| Exact Sciences Corporation | 4 | $116 |
| Novo Nordisk Inc | 3 | $52 |
| Janssen Biotech, Inc. | 2 | $51 |
| Insulet Corporation | 2 | $51 |
| Orexo US, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
Products named: BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, FARXIGA, Cologuard Collection Kit, Ozempic, TREMFYA.
Industry payments across NY — which companies pay providers there.
